semaglutide compound going away Is Compounded Away? Regulatory Updates – PlexusDx FDA restricts non-approved compounded GLP-1

Acknowledgements Special thanks for all study team for their dedication and support in this study

Retrieved 2018-04-14

Chronic stress, anxiety, and depression profoundly affect cognitive function

At the beginning of the year, Becton, Dickinson announced it would invest $110 million to expand its production capacity for prefillable syringes to support the rising demand for GLP-1 drugs

In both cases, there are important compliance and PBM contractual considerations that need to be explored and fully vetted as part of decision making

Nevertheless, GLP-1RA therapy is associated with a pattern of adverse events affecting their safety and tolerability